Caveolin-1 is upregulated in gastric cancer and is associated with tumor progression and prognosis in patients
International Journal of Clinical and Experimental Pathology · 2026
DOI: 10.62347/bmia4742 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2026. Verfasst von Li-Jing Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University Dongyang, Zhejiang, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University Dongyang, Zhejiang, China.
- Department of Medical Oncology, Affiliated Dongyang Hospital of Wenzhou Medical University Dongyang, Zhejiang, China.
Zitieren
APA
Jiang, L. J., Lu, S. P., Wang, Y., Shao, J. K., Huang, B. F., & Wang, C. Q. (2026). Caveolin-1 is upregulated in gastric cancer and is associated with tumor progression and prognosis in patients. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/bmia4742
Vancouver
Jiang LJ, Lu SP, Wang Y, Shao JK, Huang BF, Wang CQ. Caveolin-1 is upregulated in gastric cancer and is associated with tumor progression and prognosis in patients. International Journal of Clinical and Experimental Pathology. 2026. doi:10.62347/bmia4742
BibTeX
@article{Jiang2026,
author = {Jiang, Li-Jing and Lu, Shi-Ping and Wang, Yan and Shao, Jun-Kang and Huang, Bi-Fei and Wang, Chao-Qun},
title = {Caveolin-1 is upregulated in gastric cancer and is associated with tumor progression and prognosis in patients},
journal = {International Journal of Clinical and Experimental Pathology},
year = {2026},
doi = {10.62347/bmia4742}
}
EUVIMED